Home Newsfeeds Raymond James Downgrades Mercantile Bank to Outperform, Lowers Price Target to $35

Raymond James Downgrades Mercantile Bank to Outperform, Lowers Price Target to $35

Raymond James analyst David Long downgrades Mercantile Bank (NASDAQ:MBWM) from Strong Buy to Outperform and lowers the price target from $44 to $35.

byBenzinga Newsdesk

October 6, 2022

1 minute read

Raymond James analyst David Long downgrades Mercantile Bank (NASDAQ:MBWM) from Strong Buy to Outperform and lowers the price target from $44 to $35.

Google Announces Oct. 4 Event: Pixel 8 Series, Pixel Watch 2 Expected To Launch

By Rounak Jain

August 30, 2:43 PM

Google has announced a press event scheduled for Oct. 4 in New York City. It is expected to announce the Pixel 8 series and Pixel Watch 2.

GOOG

News
Tech

Apple ID Hack And Phone Number Change Leave Users Without iCloud, No Help From iPhone Maker

By Rounak Jain

November 27, 11:03 AM

If your Apple ID ever gets hacked and the hacker manages to change the phone number linked to the ID, Apple will not be able to help you.

AAPL

‘Champion Sale Process Enters Final Phase: Source’ – Woman’sWearDaily; Hanesbrands Shares Moves Higher

By Benzinga Newsdesk

January 18, 4:56 PM

https://wwd.com/business-news/financial/champion-sale-process-bids-february-hanesbrands-goldman-1236136907/ The Champion sale process is pushing toward the finish line. HanesBrands fired the starting gun

HBI

Chardan Capital Initiates Coverage On Omega Therapeutics with Buy Rating, Announces Price Target of $12

By Benzinga Newsdesk

September 23, 5:46 AM

Chardan Capital analyst Keay Nakae initiates coverage on Omega Therapeutics (NASDAQ:OMGA) with a Buy rating and announces Price Target of $12.

OMGA

Raymond James Downgrades Mercantile Bank to Outperform, Lowers Price Target to $35

Related Posts

Google Announces Oct. 4 Event: Pixel 8 Series, Pixel Watch 2 Expected To Launch

Apple ID Hack And Phone Number Change Leave Users Without iCloud, No Help From iPhone Maker

‘Champion Sale Process Enters Final Phase: Source’ – Woman’sWearDaily; Hanesbrands Shares Moves Higher

Chardan Capital Initiates Coverage On Omega Therapeutics with Buy Rating, Announces Price Target of $12